Sale!

COL6A3 Gene Ullrich Congenital Muscular Dystrophy Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The COL6A3 gene is associated with Ullrich Congenital Muscular Dystrophy Type 1, a rare genetic disorder characterized by muscle weakness, joint hypermobility, and skin abnormalities. This condition is part of a group of disorders known as collagenopathies, which are caused by mutations in the genes responsible for the production of collagen VI. The COL6A3 gene, in particular, encodes one of the three alpha chains that form collagen VI, a critical component of the extracellular matrix surrounding muscle cells and other tissues.

DNA Labs UAE offers a genetic test specifically designed to identify mutations in the COL6A3 gene that are linked to Ullrich Congenital Muscular Dystrophy Type 1. This test is a crucial tool for confirming a diagnosis, which can otherwise be challenging due to the variability of symptoms and their overlap with other neuromuscular disorders. Early and accurate diagnosis through genetic testing can guide appropriate management strategies, inform prognosis, and aid in family planning by assessing the risk of passing the condition to offspring.

The cost of the COL6A3 gene test at DNA Labs UAE is 4400 AED. This investment includes the extraction of DNA from a blood sample, the sequencing of the COL6A3 gene to identify any mutations, and a comprehensive report that interprets the results. Given the specialized nature of this test and its importance in the accurate diagnosis of Ullrich Congenital Muscular Dystrophy Type 1, the cost reflects the technical expertise and resources required to conduct the analysis and provide reliable results.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

COL6A3 Gene Ullrich congenital muscular dystrophy type 1 Genetic Test

Test Details

The COL6A3 gene is associated with Ullrich congenital muscular dystrophy type 1 (UCMD1), which is a rare genetic disorder characterized by muscle weakness and joint stiffness. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the analysis of multiple genes simultaneously. In the context of UCMD1, NGS genetic testing can be used to identify any mutations or variations in the COL6A3 gene that may be causing the condition. This type of testing can provide valuable information for diagnosis, prognosis, and potential treatment options for individuals with UCMD1.

Test Name

COL6A3 Gene Ullrich congenital muscular dystrophy type 1 Genetic Test

Components

  • Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for COL6A3 Gene Ullrich congenital muscular dystrophy type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL6A3 Gene Ullrich congenital muscular dystrophy type 1.

Test Name COL6A3 Gene Ullrich congenital muscular dystrophy type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for COL6A3 Gene Ullrich congenital muscular dystrophy type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with COL6A3 Gene Ullrich congenital muscular dystrophy type 1
Test Details

The COL6A3 gene is associated with Ullrich congenital muscular dystrophy type 1 (UCMD1), which is a rare genetic disorder characterized by muscle weakness and joint stiffness.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the analysis of multiple genes simultaneously. In the context of UCMD1, NGS genetic testing can be used to identify any mutations or variations in the COL6A3 gene that may be causing the condition. This type of testing can provide valuable information for diagnosis, prognosis, and potential treatment options for individuals with UCMD1.